A 24-year-old male with past medical history of hypoplastic left heart syndrome and staged reconstructive surgery in infancy culminating in the Fontan circulation presented to the hospital with a chief complaint of chest pain described as an “elephant sitting” on his chest. Initial 12-lead electrocardiogram revealed 2-mm ST segment elevation in inferior leads, 3-mm ST-segment elevation in anterolateral precordial leads V3 and V4, and 2-mm ST-segment elevation in V5 and V6, with right axis deviation. He was transported emergently to the cardiac catheterization laboratory where coronary angiography revealed complete occlusion of multiple anomalous branches of the right coronary system with hazy appearance suggesting the presence of thrombotic material. An aspiration catheter was used successfully to reestablish TIMI grade III flow. The patient was treated with aspirin, brilinta (ticagrelor), and anticoagulation with vitamin K antagonism to prevent recurrent thromboembolic complications.
AndersonRHSmithACookAC. Hypoplasia of the left heart. Cardiol Young. 2004;14(suppl 1):13–21.
2.
MorrisCDOutcaltJMenasheVD. Hypoplastic left heart syndrome: natural history in a geographically defined population. Pediatrics. 1990;85(6):977–983.
3.
SamanekMVoriskovaM. Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: a prospective Bohemia survival study. Pediatr Cardiol. 1999;20(6):411–417.
4.
ChameidesLGaliotoFFylerDC. The Regional Infant Cardiac Program. A six year evaluation. Conn Med. 1975;39(11):709–710.
5.
BrownellLGShokeirMH. Inheritance of hypoplastic left heart syndrome (HLHS): further observations. Clin Genet. 1976;9(2):245–249.
6.
FeitLRCopelJAKleinmanCS. Foramen ovale size in the normal and abnormal human fetal heart: an indicator of transatrial flow physiology. Ultrasound Obstet Gynecol. 1991;1(5):313–319.
7.
LuriePR. Changing concepts of endocardial fibroelastosis. Cardiol Young. 2010;20(2):115–123.
8.
TabbuttSDominguezTERavishankarC. Outcomes after the stage I reconstruction comparing the right ventricular to pulmonary artery conduit with the modified Blalock Taussig shunt. Ann Thorac Surg. 2005;80(5):1582–1590; discussion 1590-1591.
9.
MahleWTSprayTLWernovskyGGaynorJWClarkBJIII. Survival after reconstructive surgery for hypoplastic left heart syndrome: a 15-year experience from a single institution. Circulation. 2000;102(19 suppl 3):iii136–iii141.
10.
TibballsJKawahiraYCarterBGDonathSBrizardCWilkinsonJ. Outcomes of surgical treatment of infants with hypoplastic left heart syndrome: an institutional experience 1983–2004. J Paediatr Child Health. 2007;43(11):746–751.
11.
GaynorJWBridgesNDCohenMI. Predictors of outcome after the Fontan operation: is hypoplastic left heart syndrome still a risk factor?J Thorac Cardiovasc Surg. 2002;123(2):237–245.
12.
OechslinENHarrisonDAConnellyMSWebbGDSiuSC. Mode of death in adults with congenital heart disease. Am J Cardiol. 2000;86(10):1111–1116.
13.
AndersonJBBeekmanRH 3rdKuglerJD. National pediatric cardiology quality improvement collaborative. improvement in interstage survival in a national pediatric cardiology learning network. Circ Cardiovasc Qual Outcomes. 2015;8(4):428–436. doi:10.1161/CIRCOUTCOMES.115.001956. PMID:26058717.
14.
PundiKNJohnsonJNDearaniJA. 40-year follow-up after the Fontan operation long-term outcomes of 1,052 patients. J Am Coll Cardiol. 2015;66(15):1700–1710.
15.
KhairyPFernandesSMMayerJEJr. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117(1):85–92.
16.
MonaglePCochraneAMcCrindleBBensonLWilliamsWAndrewM. Editorial: thromboembolic complications after Fontan procedures—the role of prophylactic anticoagulation. J Thorac Cardiovasc Surg. 1998;115(3):493–498.
17.
KaulitzRZiemerGRauchR. Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis). J Thorac Cardiovasc Surg. 2005;129(3):569–575.
18.
JahangiriMRossDBRedingtonANLincolnCShinebourneEA. Thromboembolism after the Fontan procedure and its modifications. Ann Thorac Surg. 1994;58(5):1409–1413;discussion 1413-1414.
19.
MahnkeCBBoyleGJJanoskyJESiewersRDPigulaFA. Anticoagulation and incidence of late cerebrovascular accidents following the Fontan procedure. Pediatr Cardiol. 2005;26(1):56–61.
20.
BallingGVogtMKaemmererHEickenAMeisnerHHessJ. Intracardiac thrombus formation after the Fontan operation. J Thorac Cardiovasc Surg. 2000;119(4 pt 1):745–752.
21.
HastingsRSMcElhinneyDBSaricMNgaiCSkolnickAH. Embolic myocardial infarction in a patient with a Fontan circulation. World J Pediatr Congenit Heart Surg. 2014;5(4):631–634. doi:10.1177/2150135114540180.
22.
MorchiGSWolfeRRKayJD. Antiphospholipid syndrome leading to myocardial infarction in a Fontan patient 17 years after Norwood palliation. Congenit Heart Dis. 2009;4(1):54–58. doi:10.1111/j.1747 0803.2008.00217.
23.
KonstantinovIEPugaFJAlexi-MeskishviliVV. Thrombosis of intracardiac or extracardiac conduits after modified Fontan operation in patients with azygous continuation of the inferior vena cava. Ann Thorac Surg. 2001;72(5):1641–1644.
24.
ErmisPRMoralesDL. The adult Fontan patient: update for 2011. Methodist Debakey Cardiovasc J. 2011;7(2):3–8.
25.
CoonPDRychikJNovelloRT. Thrombus formation after the Fontan operation. Ann Thorac Surg. 2001;71(6):1990–1994.
26.
OdegardKCZurakowskiDDiNardoJA. Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion. J Thorac Cardiovasc Surg. 2009;137(4):934–941.
27.
MonaglePCochraneARobertsR. Fontan anticoagulation study group. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol. 2011;58(6):645–651. doi:10.1016/j.jacc.2011.01.061. PMID:21798429.
28.
WarnesCAWilliamsRGBashoreTM. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(23):e1–e121.
